Home › Research › Long-term cohort studies
Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia
van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM.. Stroke, 2005-11-03
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background and purpose Vascular and inflammatory factors may play an important role in the pathogenesis of dementia. Studies reported an association between plasma levels of inflammation markers and the risk of dementia. Both fibrinogen and C-reactive protein are considered inflammatory markers.
What this study adds
Evidence grade: Moderate
This is a trial of 2,835 participants. This study investigated whether the inflammatory and clotting marker fibrinogen, and C-reactive protein, are associated with dementia. It is about a possible risk marker, not about treating, curing or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
van Oijen, M., Witteman, J. C., Hofman, A., Koudstaal, P. J., & Breteler, M. M. (2005). Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke. https://doi.org/10.1161/01.str.0000189721.31432.26
Vancouver
van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke. 2005. doi:10.1161/01.str.0000189721.31432.26. PMID: 16269641.
BibTeX
@article{vanoijen2005-16269641,
author = {van Oijen, M. and Witteman, J. C. and Hofman, A. and Koudstaal, P. J. and Breteler, M. M.},
title = {{Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia}},
journal = {Stroke},
year = {2005},
doi = {10.1161/01.str.0000189721.31432.26},
pmid = {16269641},
url = {https://doi.org/10.1161/01.str.0000189721.31432.26}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Studies reported an association between plasma levels of inflammation markers and the risk of dementia.
- Both fibrinogen and C-reactive protein are considered inflammatory markers.
- Fibrinogen also has important hemostatic properties.
- We investigated the association of fibrinogen and C-reactive protein with dementia.
Why it matters
This study investigated whether the inflammatory and clotting marker fibrinogen, and C-reactive protein, are associated with dementia. It is about a possible risk marker, not about treating, curing or preventing Alzheimer's disease.
Study details
- Participants2,835
- Evidence strengthModerate
How this study scored 64/100
Published in a peer-reviewed journal, and it is a randomized controlled trial. Scored zero for effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Stroke) |
| Journal's citation record | 3 / 4 | Stroke: journal h-index 455 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomized controlled trial (from PubMed type “Randomized Controlled Trial”) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2005 — older than 20 years, still counted |
| Sample size | 3 / 4 | 2,835 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 1 / 2 | Randomized (as stated in the record) |
| Times cited | 5 / 7 | Cited 223 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.7 citations a year over 23 year(s) since 2005 |
| Impact for its field and year | 3 / 6 | Cited 3.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 9 other studies in this library |
| Still being cited | 2 / 4 | Cited 29 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Monique M.B. Breteler: h-index 162 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 16269641) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 64 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
9 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Long-term cohort studies from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.